Willingdon Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-36
Closed -$4K 579
2019
Q3
$4K Buy
+36
New +$3.42K ﹤0.01% 297
2019
Q2
Sell
-15
Closed -$1K 380
2019
Q1
$1K Sell
15
-105
-88% -$9.18K ﹤0.01% 358
2018
Q4
$8K Sell
120
-50,392
-100% -$3.72M ﹤0.01% 278
2018
Q3
$4.52M Buy
50,512
+4,348
+9% +$384K 1.23% 21
2018
Q2
$3.67M Buy
46,164
+1,520
+3% +$126K 1.12% 27
2018
Q1
$3.98M Buy
44,644
+10,817
+32% +$1.04M 1.26% 21
2017
Q4
$3.53M Buy
33,827
+14,757
+77% +$1.67M 1.16% 25
2017
Q3
$2.78M Buy
19,070
+652
+4% +$88.8K 1.01% 39
2017
Q2
$2.39M Buy
18,418
+9,304
+102% +$1.14M 0.95% 46
2017
Q1
$1.13M Buy
9,114
+268
+3% +$32.1K 0.46% 85
2016
Q4
$1.02M Buy
8,846
+348
+4% +$38.8K 0.48% 78
2016
Q3
$888K Buy
8,498
+76
+0.9% +$8.22K 0.45% 90
2016
Q2
$830K Buy
8,422
+624
+8% +$64.5K 0.43% 84
2016
Q1
$781K Sell
7,798
-2,000
-20% -$206K 0.48% 72
2015
Q4
$1.17M Sell
9,798
-5,752
-37% -$665K 1.07% 46
2015
Q3
$1.68M Sell
15,550
-147
-0.9% -$18.2K 2% 14
2015
Q2
$1.82M Sell
15,697
-1,603
-9% -$183K 1.74% 15
2015
Q1
$1.99M Sell
17,300
-4,742
-22% -$567K 1.66% 19
2014
Q4
$2.47M Sell
22,042
-117
-0.5% -$12.3K 1.55% 23
2014
Q3
$2.1M Buy
22,159
+577
+3% +$52.1K 1.38% 31
2014
Q2
$1.85M Buy
+21,582
New +$1.64M 1.28% 34

Other funds holding CELG

Willingdon Wealth Management's CELG Position: Q4 2019 in Review

Willingdon Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36 shares — an estimated $4K sold.

Willingdon Wealth Management first reported a position in CELG in Q2 2014 and held it in 21 quarters. The position peaked at $4.52M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Willingdon Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Willingdon Wealth Management sold 36 Celgene Corp shares in Q4 2019, an estimated $4K.
  • Willingdon Wealth Management first reported a position in Celgene Corp in Q2 2014 and held it in 21 quarters.
  • Willingdon Wealth Management's Celgene Corp position peaked at $4.52M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Willingdon Wealth Management's 13F filing for Q4 2019, filed 10 Feb 2020.